Stock Market & Financial Investment News

News Breaks February 26, 2013 06:24 EDT MRK, BMY Merck, Bristol-Myers diabetes drugs tied to pancreatitis risk, Bloomberg says Diabetes drugs sold by Merck & Co. (MRK) and Bristol-Myers Squibb Co. (BMY) may double a user’s risk of developing an inflammation of the pancreas linked to cancer and kidney failure, according to the analysis today in the journal JAMA Internal Medicine, reports Bloomberg. Both drugs increase GLP-1, a hormone that stimulates insulin production from the pancreas. Reference Link News For MRK;BMY From The Last 14 Days Check below for free stories on MRK;BMY the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. 1 | 2 | all recent news | >> May 22, 2013 16:16 EDT MRK FDA panel votes 13-3 that Merck insomnia drug safe in low doses, Bloomberg says Subscribe for More Information 16:00 EDT BMY, MRK Options Update; May 22, 2013 Subscribe for More Information 14:52 EDT MRK FDA panel says Merck insomnia drug effective as sleep aid, Bloomberg reports Subscribe for More Information 10:33 EDT BMY Bristol-Myers jumps after Citi ups rating on cancer potential Subscribe for More Information 10:16 EDT BMY Bristol-Myers spikes higher following upgrade, levels to watch Subscribe for More Information 10:00 EDT BMY On The Fly: Analyst Upgrade Summary Subscribe for More Information 09:39 EDT MRK Active equity option families trading Subscribe for More Information 07:45 EDT MRK FDA Peripheral & Central Nervous System Drugs Advisory Committee holds a meeting Subscribe for More Information 06:05 EDT BMY Bristol-Myers upgraded to Buy from Neutral at Citigroup Subscribe for More Information May 21, 2013 18:56 EDT MRK On The Fly: After Hours Movers Subscribe for More Information 17:03 EDT MRK Merck announces $5B share repurchase Subscribe for More Information 17:01 EDT MRK Merck announces $5B accelerated share repurchase Subscribe for More Information 07:44 EDT MRK Sachs Associates to host a forum Subscribe for More Information 07:34 EDT BMY UBS to host a conference Subscribe for More Information 07:24 EDT BMY Global Health Care to host a conference Subscribe for More Information May 20, 2013 17:49 EDT MRK Merck sleep drug effective, dosages questioned, WSJ reports Subscribe for More Information 10:03 EDT BMY Shire advances after report renews takeover speculation Subscribe for More Information 07:32 EDT MRK Society for Information Display / IHS to host a conference Display Week 2013 is being held in Vancouver, British Columbia on May 19-24. 06:30 EDT BMY Leerink estimates Shire takeout value at least $110 per share Leerink says a takeover price for Shire (SHPG) would need to be at least $110 per share in order to get the company's board to consider a sale. The firm notes a Daily Mail report last night said Bristol-Myers (BMY) has engaged advisors to study an acquisition of Shire and that Shire's CEO has contacted bankers to consider anti-takeover measures. Leerink believes a Bristol-Myers takeover of Shire would make sense and keeps an Outperform rating on Shire. 06:25 EDT BMY Shire may return cash to thwart takeover, Daily Mail reports Subscribe for More Information 1 | 2 | all recent news | >> Sign up for a free trial to see the rest of the stories you've been missing.